- Investing Ideas
- Swedish Pharmaceuticals & Biotech Pure Equity Growth
Swedish Pharmaceuticals & Biotech Pure Equity Growth
Results
3
0 new
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
3 companies
Camurus
Market Cap: SEK 30.7b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 513.00
7D
-5.6%
1Y
-12.9%
BioArctic
Market Cap: SEK 25.4b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 286.00
7D
0.4%
1Y
45.1%
Bonesupport Holding
Market Cap: SEK 14.4b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 218.20
7D
-3.2%
1Y
-17.6%